Botanical species · safety record

Piper betle

The EFSA Compendium of Botanicals holds 15 constituent measurements, 2 adverse-effect records and 2 genotoxicity assays for Piper betle. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Piper betle L.

15Constituent measurements
4Safety records
7Cited sources
6Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 6 licensed products naming Piper betle as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Leaf
  • leaf standardized extract

What the records describe

Constituents measured

  • Eugenol2
  • Phenylpropanoids2
  • Cardiac glycosides1
  • Isoquinoline alkaloids1
  • Lignans1
  • Myrcene1
  • P-coumaric acid1
  • Piperidine alkaloids1
  • Piperine1
  • Piperlonguminine1

Plant parts

  • Leaves12
  • Stem4
  • stalk4
  • Flower1

Preparations

  • Solvent extraction14
  • Essential oil3

Effect types

  • Digestive2

Target tissues

  • Digestive2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
EugenolLeavesEssential oil6.4 PercentNuclear Magnetic Resonance (NMR)Resolve DOI
Isoquinoline alkaloidsLeavesSolvent extractionChromatographic testsResolve DOI
MyrceneLeavesEssential oil1.1 PercentNuclear Magnetic Resonance (NMR)Resolve DOI
PhenylpropanoidsFlowerSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
PiperineStem / stalkSolvent extractionChromatographic testsResolve DOI
PiperlonguminineStem / stalkSolvent extractionChromatographic testsResolve DOI
SafroleLeavesEssential oil52.7 PercentNuclear Magnetic Resonance (NMR)Resolve DOI
Cardiac glycosidesLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
EugenolLeavesSolvent extractionHPLC-DADNo resolvable identifier
LignansStem / stalkSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
P-coumaric acidLeavesSolvent extractionHPLC-DADNo resolvable identifier
PhenylpropanoidsLeavesSolvent extractionHPLC-DADNo resolvable identifier
Piperidine alkaloidsStem / stalkSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
SaponinsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveLeavesSolvent extractionIn vitroNo resolvable identifier
DigestiveDigestiveLeavesSolvent extractionIn vitroNo resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
Positivegene mutationbacterial reverse mutation assaySalmonella typhimurium (as organism)WithoutResolve DOI
Positivechromosome aberrationchromosome aberration assayHamster (as animal)Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Oliveira, Andreia P., Ferreira, Joana G., Riboira, Sofia., Andrade, Paula B., Valentao, Patricia. Bioactive Natural Products from Piper betle L. Leaves and their alpha-Glucosidase Inhibitory Potential . Records of natural products, 2016, vol. 10, no. 6, p. 771-781.
  2. Mohottalage, Susantha., Tabacchi, Raffaele., Guerin, Patrick M. Components from Sri Lankan Piper betle L. leaf oil and their analogues showing toxicity against the housefly, Musca domestica . Flavour and fragrance journal, 2007, vol. 22, no. 2, p. 130-138. DOI
  3. LeeChen, SF., Chen, CL., Ho, LY., Hsu, PC., Chang, JT., Sun, CM., Chi, CW., Liu, TY. Role of oxidative DNA damage in hydroxychavicol-induced genotoxicity. Mutagenesis, 1996, vol. 11, no. 5, p. 519-523. DOI
  4. De Vera, J.S., De Castro, M.E.G., Dulay, R.M.R. Phytochemical constituents and teratogenic effect of lyophilized extracts of Bixa orellana L. (Achuete) and Piper betle L. (Ikmo) leaves in Danio rerio Embryos. Der pharma chemica, 2016, vol. 8, no. 18, p. 432-437.
  5. Huang, Xiangzhong., Yin, Yan., Huang, Wenquan., Sun, Kuizong., Cheng, Chunmei., Bai, Lian., Dai, Yun. Alkaloids and lignans from stems of Piper betle .. Zhongguo zhong yao za zhi = zhongguo zhongyao zazhi = china journal of chinese materia medica, 2010, vol. 35, no. 17, p. 2285-8.
  6. Parmar, V.S., Jain, S.C., Gupta, S., Talwar, S., Rajwanshi, V.K., Kumar, R., Azim, A., Malhotra, S., Kumar, N., Jain, R., Sharma, N.K., Tyagi, O.D., Lawrie, S.J., Errington, W., Howarth, O.W., Olsen, C.E., Singh, S.K., Wengel, J. Polyphenols and alkaloids from piper species. Phytochemistry, 1998, vol. 49, no. 4, p. 1069-1078. DOI
  7. Srividya, Srinivasan., Pillai, Subramanian Iyyam., Subramaniana, Sorimuthu Pillai. Isolation and characterization of major phytochemicals from the leaves of Piper betle. Linn. International journal of pharmacy (hyderabad, india), 2015, vol. 5, no. 4, p. 1215-1233.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue